MedTrace Logo

On Demand Treatment of Reflux Disease

NCT00184522 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2011-08-09

No results posted yet for this study

Summary

A comparison of the effect of on demand treatment with a pectin-containing natural product (Aflurax) with that esomeprazole (Nexium)

Conditions

  • Gastroesophageal Reflux

Interventions

DRUG

Aflurax

DRUG

esomeprazole

Sponsors & Collaborators

  • Ferrosan AS

    collaborator INDUSTRY

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Per G Farup, PhD · Norwegian University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-08-31
Primary Completion
2004-11-30
Completion
2004-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00184522 on ClinicalTrials.gov